SB 140-FN (2013): requiring a pharmacy to substitute generically equivalent drugs for any prescription paid for by state funds.

Cite this page

Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.

MLA: “SB 140-FN (2013): requiring a pharmacy to substitute generically equivalent drugs for any prescription paid for by state funds.” Granite Record, https://graniterecord.org/bill/2013/sb140. Accessed 24 Oct. 2026.
APA: Granite Record. (n.d.). SB 140-FN (2013): requiring a pharmacy to substitute generically equivalent drugs for any prescription paid for by state funds. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2013/sb140
Chicago: Granite Record. “SB 140-FN (2013): requiring a pharmacy to substitute generically equivalent drugs for any prescription paid for by state funds.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2013/sb140.
BibTeX: @misc{bill-2013-sb140, title = {SB 140-FN (2013): requiring a pharmacy to substitute generically equivalent drugs for any prescription paid for by state funds.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2013/sb140}, note = {Accessed 24 Oct. 2026} }

SB 140-FN (2013)

requiring a pharmacy to substitute generically equivalent drugs for any prescription paid for by state funds.

Status: Killed
Term: 2013-2014
House committee: Commerce and Consumer Affairs
Senate committee: Commerce
Subject: Miscellaneous

The Story

It was introduced on January 3, 2013 and referred to the Senate Commerce committee. The committee held a public hearing on February 5, 2013. The committee recommended that the Senate pass it with changes (amendment 2013-0521s). The committee's amendment (0521s) was adopted on a voice vote on March 7, 2013, changing the text of the bill. On March 7, 2013 the Senate voted to pass it with changes on a voice vote, then referred it on to the Senate Finance committee. The committee recommended that the Senate pass it. On March 21, 2013 the Senate voted to pass it on a voice vote and ordered it to a third reading. It crossed to the House on March 27, 2013 and was referred to the House Commerce and Consumer Affairs committee. The committee held a public hearing on April 11, 2013. The committee met in executive session on April 18, 2013 to vote on its recommendation. The committee voted unanimously, 18–0, to recommend that the House kill it, and the report was placed on the consent calendar. On April 24, 2013 the House voted to kill it on a voice vote.

Hearings and Sessions

February 5, 2013, 2:10 PM: hearing, Senate Commerce, LOB 101
April 11, 2013, 11:00 AM: public hearing, House Commerce and Consumer Affairs, LOB 302
April 18, 2013, 11:15 AM: executive session, House Commerce and Consumer Affairs, LOB 302

Votes

March 7, 2013, Senate: Ought to Pass with Amendment 0521s — voice vote, passed
March 21, 2013, Senate: Ought to Pass — voice vote, passed
April 24, 2013, House: Inexpedient to Legislate — voice vote, passed

The Docket

January 3, 2013: Introduced and Referred to Commerce
February 5, 2013: Hearing: 2/5/13, Room 101, LOB, 2:10 p.m.; SC7
February 21, 2013: Committee Report: Ought to Pass with Amendment #2013-0521s, 3/7/13; SC10
March 7, 2013: Committee Amendment 0521s, AA, VV
March 7, 2013: Ought to Pass with Amendment 0521s, MA, VV; Refer to Finance Rule 4-5
March 13, 2013: Committee Report: Ought to Pass, 3/21/13; SC12
March 21, 2013: Ought to Pass: MA, VV; OT3rdg
March 27, 2013: Introduced and Referred to Commerce and Consumer Affairs; HJ31, PG.1076
April 11, 2013: Public Hearing: 4/11/2013 11:00 AM LOB 302
April 18, 2013: Executive Session: 4/18/2013 11:15 AM LOB 302
April 18, 2013: Committee Report: Inexpedient to Legislate for April 24 (Vote 18-0; CC); HC33, PG.1092
April 24, 2013: Inexpedient to Legislate: MA VV; HJ38, PG.1239

Laws It Would Change

RSA 318:47-d